S.T. Dupont S.A.

DPT.PA plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DPT.PA stands at 83M. In comparison, MC.PA has a market cap of 233.8B. Regarding current trading prices, DPT.PA is priced at €0.09, while MC.PA trades at €471.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DPT.PA currently has a P/E ratio of -8.80, whereas MC.PA's P/E ratio is 21.57. In terms of profitability, DPT.PA's ROE is +0.03%, compared to MC.PA's ROE of +0.16%. Regarding short-term risk, DPT.PA is more volatile compared to MC.PA. This indicates potentially higher risk in terms of short-term price fluctuations for DPT.PA.Check MC.PA's competition here

DPT.PA plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DPT.PA stands at 83M. In comparison, RMS.PA has a market cap of 175B. Regarding current trading prices, DPT.PA is priced at €0.09, while RMS.PA trades at €1,669.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DPT.PA currently has a P/E ratio of -8.80, whereas RMS.PA's P/E ratio is 38.72. In terms of profitability, DPT.PA's ROE is +0.03%, compared to RMS.PA's ROE of +0.26%. Regarding short-term risk, DPT.PA is more volatile compared to RMS.PA. This indicates potentially higher risk in terms of short-term price fluctuations for DPT.PA.Check RMS.PA's competition here

DPT.PA plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DPT.PA stands at 83M. In comparison, CDI.PA has a market cap of 81.2B. Regarding current trading prices, DPT.PA is priced at €0.09, while CDI.PA trades at €450.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DPT.PA currently has a P/E ratio of -8.80, whereas CDI.PA's P/E ratio is 17.92. In terms of profitability, DPT.PA's ROE is +0.03%, compared to CDI.PA's ROE of +0.19%. Regarding short-term risk, DPT.PA is more volatile compared to CDI.PA. This indicates potentially higher risk in terms of short-term price fluctuations for DPT.PA.Check CDI.PA's competition here

DPT.PA plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DPT.PA stands at 83M. In comparison, KER.PA has a market cap of 32.3B. Regarding current trading prices, DPT.PA is priced at €0.09, while KER.PA trades at €263.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DPT.PA currently has a P/E ratio of -8.80, whereas KER.PA's P/E ratio is -1144.35. In terms of profitability, DPT.PA's ROE is +0.03%, compared to KER.PA's ROE of +0.00%. Regarding short-term risk, DPT.PA is more volatile compared to KER.PA. This indicates potentially higher risk in terms of short-term price fluctuations for DPT.PA.Check KER.PA's competition here

DPT.PA plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DPT.PA stands at 83M. In comparison, MLCLI.PA has a market cap of 7.3M. Regarding current trading prices, DPT.PA is priced at €0.09, while MLCLI.PA trades at €1.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DPT.PA currently has a P/E ratio of -8.80, whereas MLCLI.PA's P/E ratio is N/A. In terms of profitability, DPT.PA's ROE is +0.03%, compared to MLCLI.PA's ROE of -0.77%. Regarding short-term risk, DPT.PA is more volatile compared to MLCLI.PA. This indicates potentially higher risk in terms of short-term price fluctuations for DPT.PA.Check MLCLI.PA's competition here